Identification of Difficulties During a First Request for a Personal Autonomy Allowance (IDAPA)

March 20, 2019 updated by: Rennes University Hospital

Identification of Difficulties During a First Request for a Personal Autonomy Allowance by Beneficiaries and Identification of the Role of the Attending Physician During This Request.

The objective of this study is to identify the difficulties when first applying for a first Resource Allocation (Personal autonomy allowance - APA) by beneficiaries and their relatives through a qualitative study and secondarily identification of the role of the attending physician during this request.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The APA, introduced since the French law of 2001 aims to improve the care of people with loss of autonomy.

A regular assessment of autonomy in the elderly should be carried out in order to implement ABS as early as possible. The aim is to set up the necessary home help to avoid or delay institutionalisation.

It therefore seems essential to place oneself on the side of the beneficiaries and their relatives in order to identify the difficulties encountered during a first ABS application and their expectations as to the role of the general practitioner during this application?

Study Type

Observational

Enrollment (Actual)

18

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Rennes, France, 35 042
        • Conseil Départemental -Pôle Solidarité Humaine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The population studied includes all the people who apply for a first Resource Allocation (APA) in all 6 territories of the department of Ille et Vilaine

Description

Inclusion Criteria:

  • Beneficiaries living in Ille et Vilaine
  • requesting for the first time a Resource Allocation (APA)

Or

  • Persons requesting for the first time a Resource Allocation (APA)
  • Allocation of resources for the benefit of a person residing in Ille et Vilaine

Exclusion Criteria:

  • Refusal of Resource Allocation
  • opposition to participation in the survey.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Semi-structured interview
Time Frame: through study completion, an average of 1 year
The interview guide will seek to make the beneficiaries talk about their administrative difficulties, access to information, coordination between medical and social professionals and others faced when making their first request for resource allocation (APA)
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Rennes University Hospital

Investigators

  • Principal Investigator: Emilie MENAND, MD, Rennes University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 13, 2018

Primary Completion (Actual)

November 15, 2018

Study Completion (Actual)

November 15, 2018

Study Registration Dates

First Submitted

January 30, 2019

First Submitted That Met QC Criteria

March 14, 2019

First Posted (Actual)

March 15, 2019

Study Record Updates

Last Update Posted (Actual)

March 22, 2019

Last Update Submitted That Met QC Criteria

March 20, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 35RC18_3040_IDAPA

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe